Monday, April 13 - ATGLive has officially announced the lineup and schedule for the 2026 "No Rest After Fest" concert series at the historic Saenger Theatre in New Orleans, LA... ABOUT ATG LIVE ... ABOUT ATG ENTERTAINMENT ... FOLLOW ATG LIVE..
Thursday, April 2 - Today, ATGEntertainment announces ATG Live , a newly formed concert, comedy & events division led by Senior Vice PresidentErik Newson ... "ATG Live represents an exciting next chapter for our business ... ABOUT ATG LIVE.
Specifically, ATG-201 is a CD19 targeting bispecific TCE designed to eliminate CD19-expressing B cells ... Antengene plans to submit clinical trial applications for ATG‑201 in China and Australia in the first quarter of 2026.
Antengene grants UCB worldwide exclusive rights to develop, manufacture and commercialize ATG-201, a CD19/CD3 bispecific T-cell engager (TCE) antibody, targeting B cell-related autoimmune diseases.
) UCB and Antengene enter global license agreement for ATG-201, a B cell-depleting bispecific antibody ... Specifically, ATG-201 is a CD19 targeting bispecific TCE designed to eliminate CD19-expressing B cells.